G Paoletti

1.5k total citations · 1 hit paper
29 papers, 977 citations indexed

About

G Paoletti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, G Paoletti has authored 29 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in G Paoletti's work include Cancer Treatment and Pharmacology (17 papers), Colorectal Cancer Treatments and Studies (10 papers) and Breast Cancer Treatment Studies (6 papers). G Paoletti is often cited by papers focused on Cancer Treatment and Pharmacology (17 papers), Colorectal Cancer Treatments and Studies (10 papers) and Breast Cancer Treatment Studies (6 papers). G Paoletti collaborates with scholars based in Italy, United States and Malaysia. G Paoletti's co-authors include Vittorio Gebbia, Evaristo Maiello, Francesco Giuliani, Massimo Lopez, Luigi Manzione, Giuseppe Colucci, Giacomo Cartenì, S. Romito, Giuseppe Pezzella and Stefano Cordio and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

G Paoletti

28 papers receiving 930 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

2005 586 citations Giuseppe Colucci, Vittorio Gebbia et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Paoletti Italy	13	781	352	232	152	137	29	977
Joe McKendrick Australia	7	865 1.1×	420 1.2×	292 1.3×	170 1.1×	176 1.3×	9	1.1k
R Castan France	4	829 1.1×	392 1.1×	288 1.2×	117 0.8×	166 1.2×	6	1.0k
Roger Sidhu United States	13	715 0.9×	388 1.1×	152 0.7×	156 1.0×	248 1.8×	29	904
Joseph J. Schulz United States	6	1.3k 1.7×	533 1.5×	469 2.0×	195 1.3×	148 1.1×	8	1.5k
Roberto Moretto Italy	15	623 0.8×	207 0.6×	135 0.6×	178 1.2×	263 1.9×	69	872
Rodolfo Mattioli Italy	17	707 0.9×	306 0.9×	85 0.4×	141 0.9×	145 1.1×	61	995
Janja Ocvirk Slovenia	17	1.0k 1.3×	376 1.1×	226 1.0×	231 1.5×	179 1.3×	69	1.3k
Federico Nasroulah United States	11	824 1.1×	395 1.1×	190 0.8×	159 1.0×	153 1.1×	29	993
Auxiliadora Gómez‐España Spain	11	605 0.8×	369 1.0×	111 0.5×	133 0.9×	158 1.2×	19	782
Donatella Marino Italy	13	402 0.5×	181 0.5×	207 0.9×	220 1.4×	104 0.8×	34	738

Countries citing papers authored by G Paoletti

Since Specialization

Citations

This map shows the geographic impact of G Paoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Paoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Paoletti more than expected).

Fields of papers citing papers by G Paoletti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Paoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Paoletti. The network helps show where G Paoletti may publish in the future.

Co-authorship network of co-authors of G Paoletti

This figure shows the co-authorship network connecting the top 25 collaborators of G Paoletti. A scholar is included among the top collaborators of G Paoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Paoletti. G Paoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pizzuti, Laura, Eriseld Krasniqi, Chiara Mandoj, et al.. (2020). Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial. Cancers. 12(4). 849–849. 2 indexed citations

Barnabei, Agnese, Silvia Carpano, Marta Bianchini, et al.. (2020). Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review. Frontiers in Oncology. 10. 582394–582394. 18 indexed citations

Lauro, Luigi Di, Patrizia Vici, Silverio Tomao, et al.. (2013). Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer. Gastric Cancer. 17(4). 718–724. 17 indexed citations

Vici, Patrizia, Domenico Sergi, Laura Pizzuti, et al.. (2013). Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients. Journal of Experimental & Clinical Cancer Research. 32(1). 49–49. 16 indexed citations

Mottolese, Marcella, Anna Maria Cianciulli, Angela Torsello, et al.. (2010). Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab. Journal of Translational Medicine. 8(1). 36–36. 19 indexed citations

Vici, Patrizia, Paolo Foggi, Silvia Carpano, et al.. (2006). High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.. PubMed. 25(1). 39–44. 9 indexed citations

Lauro, Luigi Di, Filiberto Belli, Maria Arena, et al.. (2005). Epirubicin, cisplatin and docetaxel combination therapy for metastatic gastric cancer. Annals of Oncology. 16(9). 1498–1502. 12 indexed citations

Maiello, Evaristo, Vittorio Gebbia, Francesco Giuliani, et al.. (2005). FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM). Annals of Oncology. 16. iv56–iv60. 16 indexed citations

Zupi, Gabriella, Marco Scarsella, Carmen D’Angelo, et al.. (2005). Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells. Cancer Biology & Therapy. 4(8). 866–871. 14 indexed citations

10.

Vici, Patrizia, Paolo Foggi, Giuseppe Colucci, et al.. (2005). Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.. PubMed. 25(2B). 1309–14. 3 indexed citations

11.

Maiello, Evaristo, R.V. Iaffaioli, Rosa Tambaro, et al.. (2004). A dose finding followed by a phase II study of oral UFT (uracil/tegafur) and lv (leucovorin) plus i.v. mitomycin (MMC) in patients (pts) with metastatic colorectal cancer (MCRC): Phase I results. Journal of Clinical Oncology. 22(14_suppl). 3709–3709. 1 indexed citations

12.

Maiello, Evaristo, Vittorio Gebbia, Francesco Giuliani, et al.. (2000). 5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group. Annals of Oncology. 11(8). 1045–1052. 27 indexed citations

13.

Carpano, Silvia, Claudia Manfredi, Luigi Di Lauro, et al.. (1999). [Gemcitabine in advanced stage soft tissue sarcoma: a phase II study].. PubMed. 150(1). 17–20. 22 indexed citations

14.

Maiello, Evaristo, Francesco Giuliani, Vittorio Gebbia, et al.. (1999). Folinic acid (FA) and 5-fluorouracil (FU) alone or with irinotecan (CPT-11) for advanced colorectal cancer (ACC): Preliminary results of a randomized phase II trial. European Journal of Cancer. 35. S71–S71. 1 indexed citations

15.

López, M, Patrizia Vici, Francesca Conti, et al.. (1998). Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas.. Journal of Clinical Oncology. 16(1). 86–92. 110 indexed citations

16.

Carpano, Silvia, et al.. (1998). [Phase II study of docetaxel in patients with advanced stage soft tissue sarcoma].. PubMed. 149(2). 121–5. 2 indexed citations

17.

López, M, Patrizia Vici, Luigi Di Lauro, et al.. (1995). Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer. European Journal of Cancer. 31(10). 1611–1614. 12 indexed citations

18.

López, M, Luigi Di Lauro, G Paoletti, et al.. (1995). Sequential biochemotherapy for metastatic colorectal cancer using fluorouracil, folinic acid, thymopentin and interleukin-2: Clinical and immunological effects. Annals of Oncology. 6(10). 1011–1017. 13 indexed citations

19.

López, M, Silvia Carpano, A Cancrini, et al.. (1993). Phase II study of continuous intravenous infusion of recombinant interleukin-2 in patients with advanced renal cell carcinoma. Annals of Oncology. 4(8). 689–691. 8 indexed citations

20.

Lopez, Massimo, et al.. (1991). Thymopentin and interleukin-2 in combination with 5-fluorouracil and leucovorin in metastatic colorectal adenocarcinoma: Preliminary results. Journal of Surgical Oncology. 48(S2). 108–111. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact